Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: ("physician" OR "physical")
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
author_facet:"Canadian Agency for Drugs and Technologies in Health"
dewey-ones:"330 - Economics"
Showing
1
-
20
of
21
Search:
'("physician" OR "physical")'
,
query time: 0.03s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
Bobath therapy for patients with neurological conditions : a review of clinical effectiveness, cost-effectiveness, and guidelines
by
Gray, Casey
,
Ford, Caitlyn
Published 2018
CADTH
Subjects:
“
...
Physical
Therapy Modalities / standards...
”
Read Now
2
Bobath therapy for patients with neurological conditions : a review of clinical effectiveness, cost-effectiveness, and guidelines
by
Gray, Casey
,
Ford, Caitlyn
Published 2018
CADTH
Subjects:
“
...
Physical
Therapy Modalities / standards...
”
Read Now
3
CADTH Canadian Drug Expert Committee recommendation: Tocilizumab (Actemra - Hoffmann-La Roche Limited) : indication : giant cell arteritis
Published 2018
CADTH
“
...
physician
with experience in the diagnosis and management of GCA. A reduction in price...
”
Read Now
4
CADTH Canadian Drug Expert Committee recommendation: Nitisinone (Orfadin -- Sobi Canada Inc.) : indication: the treatment of adult and pediatric patients with hereditary tyrosinemi...
Published 2018
CADTH
“
... is prescribed by a
physician
with experience in the diagnosis and management of hereditary tyrosinemia type-1...
”
Read Now
5
CADTH Canadian Drug Expert Committee recommendation: Apomorphine hydrochloride (Movapo -- Paladin Labs Inc.) : indication : Parkinson's disease
Published 2018
CADTH
“
...
physician
with experience in the diagnosis and management of PD. Reduction in price...
”
Read Now
6
CADTH Canadian Drug Expert Committee recommendation: Tocilizumab (Actemra - Hoffmann-La Roche Limited) : indication : giant cell arteritis
Published 2018
CADTH
“
...
physician
with experience in the diagnosis and management of GCA. A reduction in price...
”
Read Now
7
Disposable, non-sterile gloves for minor surgical procedures : a review of clinical evidence
by
Ho, Chuong
,
Adams, Alison
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
... in healthcare settings such as
physician
offices, dental offices or emergent care settings. Despite...
”
Read Now
8
CADTH Canadian Drug Expert Committee recommendation: Nitisinone (Orfadin -- Sobi Canada Inc.) : indication: the treatment of adult and pediatric patients with hereditary tyrosinemi...
Published 2018
CADTH
“
... is prescribed by a
physician
with experience in the diagnosis and management of hereditary tyrosinemia type-1...
”
Read Now
9
CADTH Canadian Drug Expert Committee recommendation: Nitisinone (MDK-Nitisinone -- mendeliKABs inc.) : indication : the treatment of adult and pediatric patients with hereditary ty...
Published 2018
Canadian Agency for Drugs and Technologies in Health
“
... in patients with an established diagnosis of HT-1. The drug is prescribed by a
physician
with experience...
”
Read Now
10
CADTH Canadian Drug Expert Committee recommendation: Apomorphine hydrochloride (Movapo -- Paladin Labs Inc.) : indication : Parkinson's disease
Published 2018
CADTH
“
...
physician
with experience in the diagnosis and management of PD. Reduction in price...
”
Read Now
11
Disposable, non-sterile gloves for minor surgical procedures : a review of clinical evidence
by
Ho, Chuong
,
Adams, Alison
Published 2017
Canadian Agency for Drugs and Technologies in Health
“
... in healthcare settings such as
physician
offices, dental offices or emergent care settings. Despite...
”
Read Now
12
CADTH Canadian Drug Expert Committee recommendation: Sofosbuvir/Velpatasvir/Voxilaprevir (Vosevi -- Gilead Sciences Canada, Inc.) : indication : chronic hepatitis C virus infection
Published 2018
CADTH
“
...
physician
with experience in the diagnosis and management of HCV infection. Drug plan cost for SOF/VEL/VOX...
”
Read Now
13
CADTH Canadian Drug Expert Committee recommendation: Sofosbuvir/Velpatasvir/Voxilaprevir (Vosevi -- Gilead Sciences Canada, Inc.) : indication : chronic hepatitis C virus infection
Published 2018
CADTH
“
...
physician
with experience in the diagnosis and management of HCV infection. Drug plan cost for SOF/VEL/VOX...
”
Read Now
14
Pharmacoeconomic review report: Nitisinone (Nitisinone tablets) (Cycle Pharmaceuticals Ltd.) : indication : for the treatment of patients with hereditary tyrosinemia type 1 in comb...
Published 2018
Canadian Agency for Drugs and Technologies in Health
“
... and phenylalanine if the following conditions are met: the drug is prescribed by a
physician
with experience...
”
Read Now
15
Pharmacoeconomic review report: Omalizumab (Xolair)
Published 2017
CADTH
Read Now
16
Pharmacoeconomic review report: Omalizumab (Xolair)
Published 2017
CADTH
Read Now
17
Pharmacoeconomic review report: Nitisinone (Nitisinone tablets) (Cycle Pharmaceuticals Ltd.) : indication : for the treatment of patients with hereditary tyrosinemia type 1 in comb...
Published 2018
Canadian Agency for Drugs and Technologies in Health
“
... and phenylalanine if the following conditions are met: the drug is prescribed by a
physician
with experience...
”
Read Now
18
Optimal warfarin management for prevention of thromboembolic events in patients with atrial fibrillation
Published 2011
Canadian Agency for Drugs and Technologies in Health
Read Now
19
Tesamorelin (Egrifta)
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
... (lifestyle modifications, nutrition, and
physical
activity) in patients with HIV-associated lipohypertrophy...
”
Read Now
20
Pharmacoeconomic review report: Nitisinone (Orfadin) (Sobi Canada Inc.)
Published 2018
CADTH
“
...
physical
examination, patient history, and specialized tests (including urine succinylacetone levels...
”
1
2
Back
Narrow Search
Remove Filters
Clear Filter
Author: Canadian Agency for Drugs and Technologies in Health
Clear Filter
Classification: 330 - Economics
Year of Publication
From:
To:
Classification
330 - Economics
610 - Medicine & health
11
140 - Specific philosophical schools
2
700 - The arts; fine & decorative arts
2
Language
English
21
Collection
National Center for Biotechnology Information
21
Author
Canadian Agency for Drugs and Technologies in Health
CADTH Canadian Drug Expert Committee
9
Adams, Alison
2
Canadian Agency for Drugs and Technologies in Health Rapid Response Service
2
Ford, Caitlyn
2
Gray, Casey
2
more ...
Ho, Chuong
2
see all ...
less ...
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?filter%5B%5D=author_facet%3A%22Canadian+Agency+for+Drugs+and+Technologies+in+Health%22&filter%5B%5D=dewey-ones%3A%22330+-+Economics%22&lookfor=%28%22physician%22+OR+%22physical%22%29&type=AllFields
Send by Email
×
Loading...